T. Rowe Price Investment Management, Inc. Immunocore Holdings PLC Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 7,063,896 shares of IMCR stock, worth $254 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
7,063,896
Previous 7,067,659
0.05%
Holding current value
$254 Million
Previous $222 Million
15.71%
% of portfolio
0.16%
Previous 0.14%
Shares
8 transactions
Others Institutions Holding IMCR
# of Institutions
146Shares Held
46.9MCall Options Held
325KPut Options Held
1.74M-
Rtw Investments, LP New York, NY4.87MShares$175 Million2.36% of portfolio
-
Wellington Management Group LLP Boston, MA4.78MShares$172 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.75MShares$135 Million0.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.8MShares$101 Million2.17% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$83.5 Million0.69% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.58B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...